NCT06354595

Brief Summary

The investigators evaluated and optimized the Metaverse multi-dimensional rehabilitation platform based on the use of the Metaverse multi-dimensional rehabilitation platform by colorectal cancer survivors and their families, and finally launched the Metaverse multi-dimensional rehabilitation platform.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

March 12, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 9, 2024

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

April 9, 2024

Status Verified

April 1, 2024

Enrollment Period

2 months

First QC Date

March 12, 2024

Last Update Submit

April 7, 2024

Conditions

Keywords

Metaverse multi-dimensional rehabilitation platform

Outcome Measures

Primary Outcomes (2)

  • Post-Study System Usability Questionnaire (PSSUQ) Third Edition

    The questionnaire includes three dimensions: usefulness, information quality, interface quality, and one overall evaluation item, totaling 20 items. Each item is rated on a scale from 'strongly disagree' to 'strongly agree' with scores ranging from 1 to 5. A higher score indicates higher user satisfaction.

    4th week

  • System Usability Scale (SUS)

    Used to evaluate user experience, employing the Likert 5-point scale method, consisting of 10 questions. Questions 1, 3, 5, 7, and 9 are positively worded, while questions 2, 4, 6, 8, and 10 are negatively worded. The validity of the scale is 0.85. The SUS is scored on a percentage scale. When the questionnaire score is above 70, the product is considered 'good,' and above 50 is considered 'okay.

    4th week

Secondary Outcomes (1)

  • Semi-structured interview

    4th week

Study Arms (1)

Colorectal cancer survivors and their families

OTHER

Using the Colorectal Cancer Survivor Metaverse Multidimensional Rehabilitation Platform, and provide feedback and suggestions.

Device: Multidimensional Rehabilitation in the Metaverse

Interventions

Using the multidimensional rehabilitation space in the metaverse, evaluate the platform after use.

Colorectal cancer survivors and their families

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing adjuvant therapy after radical colorectal cancer resection; Age over 18 years old, under 65 years old, non-pregnant; Volunteering to participate in the research of this topic; Mobile phones are available

You may not qualify if:

  • Patients with multiple cancers; Have special dietary needs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yuru Hu

Xiamen, Fujian, 361005, China

RECRUITING

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Yuru HU

    Xiamen University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 12, 2024

First Posted

April 9, 2024

Study Start

March 1, 2024

Primary Completion

April 30, 2024

Study Completion

May 1, 2024

Last Updated

April 9, 2024

Record last verified: 2024-04

Locations